Abstract
Although the functional interplay between mutant and wild-type Ras in driving tumor initiation and growth has been described, a clear picture of the precise ramifi cations and mechanisms of this association remains elusive, sometimes with confl icting conclusions. A report in this issue of Cancer Discovery tackles this question, which may have important implications for therapeutic strategies to block mutant Ras for cancer treatment. © 2012 American Association for Cancer Research.
Cite
CITATION STYLE
Hayes, T. K., & Der, C. J. (2013). Mutant and wild-type Ras: Co-conspirators in cancer. Cancer Discovery, 3(1), 24–27. https://doi.org/10.1158/2159-8290.CD-12-0521
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.